본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Discovery and validation of a new biomarker for heart failure diagnostic

Berry, M. (Médecine évolutive, obésité ) ; Galinier, M. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Delmas, C. (Médecine évolutive, obésité ) ; Fournier, P. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Desmoulin, F. (Médecine évolutive, obésité ) ; Turkieh, A. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Mischak, H. (Médecine évolutive, obésité ) ; Mullen, W. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Barutaut, M. (Médecine évolutive, obésité ) ; Eurlings, L. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Brunner La Rocca, H.P. (Médecine évolutive, obésité ) ; Butler, J. (et insuffisance cardiaque: approches moléculaires et cliniques, UMR UT3 CNRS 5288, Toulouse, France ) ; Roncalli, J. (Chair of p ) ; Evaristi, M.F. ; Cohen-Solal, A. ; Escamilla, R. ; Ferrieres, J. ; Koukoui, F. ; Smih, F. ; Rouet, P. ;
  • 초록  

    Background Diagnostic biomarkers for heart failure (HF) such as the natriuretic peptides (NPs) are widely used but have limitations. Innovative biomarkers could provide improved diagnostic performance. Methods We launched a prospective case-control proteomic study and investigated for polypeptides specific to HF through a capillary electrophoresis-mass spectrometry (CE-MS) proteomic analysis. The putative biomarker was identified by Orbitrap liquid chromatography-MS, validated by western blot, then by ELISA using plasmas from multicentric international cohorts. A rat model of HF was tested for biomarker expression levels. Results We identified insulin like growth factor binding protein 2 (IGFBP2) as a new diagnostic biomarker for HF with a high sensitivity and specificity (AUC=0.93; 95% CI, 0.89–0.96; P b 0.0001) in the local cohort and IGFBP2 levels provided an AUC of 0.943 (95% CI, 0.860–1.026) which gave a 87% sensitivity in AHF and 90% specificity at the cut off value previously determined in the discovery cohort, i.e. 556ng/ml. ROC curve analysis of IGFBP2 and NTproBNP showed an AUC of 0.784 (95% CI, 0.744–0.820) for IGFBP2 and a significantly higher AUC of 0.927 (95% CI, 0.900–0.949) for NT-proBNP, P Conclusion IGFBP2 is a new biomarker to diagnose HF, which could be used to provide additional information to the NPs. Animals models, will help in the evaluation of the putative IGFBP2 regulated mechanisms in HF.


 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기